Kewaunee Scientific (NASDAQ:KEQU) Releases Earnings Results

Kewaunee Scientific (NASDAQ:KEQU) issued its quarterly earnings data on Wednesday. The technology company reported $0.58 earnings per share for the quarter, Zacks reports. Kewaunee Scientific had a net margin of 3.41% and a return on equity of 14.10%.

Kewaunee Scientific Price Performance

Kewaunee Scientific stock traded down $0.98 on Wednesday, reaching $35.03. The company’s stock had a trading volume of 3,205 shares, compared to its average volume of 4,652. The business’s fifty day moving average price is $36.77 and its 200 day moving average price is $37.19. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.55 and a current ratio of 2.18. The company has a market cap of $100.47 million, a price-to-earnings ratio of 10.88 and a beta of 0.73. Kewaunee Scientific has a twelve month low of $33.27 and a twelve month high of $57.88.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Punch & Associates Investment Management Inc. grew its holdings in Kewaunee Scientific by 61.9% during the 3rd quarter. Punch & Associates Investment Management Inc. now owns 70,085 shares of the technology company’s stock worth $2,989,000 after acquiring an additional 26,785 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Kewaunee Scientific by 0.9% during the 2nd quarter. Geode Capital Management LLC now owns 24,013 shares of the technology company’s stock worth $1,410,000 after buying an additional 223 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of Kewaunee Scientific by 125.7% during the first quarter. Goldman Sachs Group Inc. now owns 19,397 shares of the technology company’s stock worth $764,000 after acquiring an additional 10,803 shares during the last quarter. Susquehanna International Group LLP bought a new position in Kewaunee Scientific in the third quarter valued at about $713,000. Finally, State Street Corp raised its holdings in Kewaunee Scientific by 4.2% during the 4th quarter. State Street Corp now owns 10,034 shares of the technology company’s stock worth $375,000 after purchasing an additional 400 shares during the last quarter. Institutional investors and hedge funds own 32.69% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Kewaunee Scientific in a report on Tuesday, June 30th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

About Kewaunee Scientific

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.